Subclinical atrial fibrillation: Implications of recent trials for guideline updates?

doi:10.4330/wjc.v18.i1.111882

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

This Article

(52)

(128)

(0)

(1239)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Cardiol. Jan 26, 2026; 18(1): 111882
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.111882

Full Size Figure Download Figure

Figure 5 The contemporary 2023 ACC/AHA guideline on the use of oral anticoagulation in subclinical atrial fibrillation. The orange zones indicate areas of low risk and obviate the need for oral anticoagulation. The green zones demarcate areas of high risk and need for oral anticoagulation. The yellow zones are a grey area and need further research.

Citation: Pradhan A, Shah S, Vishwakarma P, Singh AK. Subclinical atrial fibrillation: Implications of recent trials for guideline updates? World J Cardiol 2026; 18(1): 111882
URL: https://www.wjgnet.com/1949-8462/full/v18/i1/111882.htm
DOI: https://dx.doi.org/10.4330/wjc.v18.i1.111882

Pradhan A, Shah S, Vishwakarma P, Singh AK. Subclinical atrial fibrillation: Implications of recent trials for guideline updates? World J Cardiol 2026; 18(1): 111882 [PMID: 41607628 DOI: 10.4330/wjc.v18.i1.111882]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.